The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: Proposal of reliable and feasible strategies

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 203-210

  Pereira, Kaline Medeiros Costa ^a,b   Dellavance, Alessandra ^a,b   Andrade, Luis Eduardo Coelho ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

Antinuclear autoantibodies; Autoantibodies; Enzyme immunoassay; Extractable nuclear antigens; Systemic autoimmune rheumatic diseases

Indexed keywords

AUTOANTIBODY;

ADDRESSABLE LASER BASED IMMUNOASSAY; ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DOUBLE IMMUNODIFFUSION; ENZYME IMMUNOASSAY; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNODIFFUSION; IMMUNOLOGY TEST KIT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE; AUTOIMMUNE DISEASES; BLOOD; HIGH THROUGHPUT SCREENING; MIDDLE AGED; REPRODUCIBILITY; RHEUMATIC DISEASES; STANDARDS;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEASIBILITY STUDIES; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES;

EID: 84907311444     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.031     Document Type: Article

References (39)

1. Fernadez-Madrid F., Mattioli M. Antinuclear antibodies (ANA): immunologic and clinical significance. Semin Arthritis Rheum 1976, 6:83-124.
2. Catoggio L.J., Bernstein R.M., Black C.M., et al. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum 1983, 42:3-7.
3. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989, 44:93-151.
4. Clark G., Reichlin M., Tomasi T.B. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969, 102:117-122.
5. Mattioli M., Reichlin M. Heterogeneity of RNA protein antigen reactive with sera of patients with systemic lupus erythematosus. Arthritis Rheum 1974, 17:421-429.
6. Alspaugh M.A., Tan E.M. Antibodies to cellular antigens in Sjogren's syndrome. J Clin Invest 1975, 55:1067-1073.
7. Kurata N., Tan E. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976, 19:574-580.
8. Fritzler M.J., Wiik A., Fritzler M.L., et al. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003, 4:192-201.
9. Tan E.M., Smolen J.S., McDougal J.S., et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999, 42:455-464.
10. Phan T.G., Wong R.C.W., Adelstein S. Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol 2002, 9:1-7.
11. Martins T.B., Burlingame R., von Mühlen C.A., et al. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004, 211:1054-1059.
12. Jaskowski T.D., Schroder C., Martins T.B., et al. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens. J Clin Lab Anal 1995, 19:166-172.
13. Desplat-Jego S., Bardin N., Larida B., et al. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Ann N Y Acad Sci 2007, 1109:245-255.
14. Moder K.G., Wener M.H., Weisman M.H., et al. Measurement of antinuclear antibodies multiplex immunoassay: a prospective, multicenter clinical evaluation. J Rheumatol 2007, 4:978-986.
15. Hanly J.G., Thompson K., McCurdy G., et al. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010, 352:147-152.
16. Copple S.S., Martins T.B., Masterson C., et al. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann N Y Acad Sci 2007, 1109:464-472.
17. Orton S.M., Peace-Brewer A., Schmitz J.L., et al. Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens. Clin Diagn Lab Immunol 2004, 11:297-301.
18. Masi A.T., Rodnan G.P., Medsger T.A., et al. Preliminary criteria for the classification of systemic scleroderma (scleroderma). Subcommittee for the scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23.
19. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
20. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 1975, 2:344-3447.
21. Vitale C., Bombardieri S., Moutsopoulos H.M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347.
22. Altman R.D. Classification of disease: osteoarthritis. Semin Arthritis Rheum 1991, 20(6 Suppl. 2):40-47.
23. van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368.
24. Ouchterlony O. Diffusion-in-gel methods for immunological analysis. Prog Allergy 1958, 5:1-78.
25. Sox H. Probability theory in the use of diagnostic tests: an introduction to critical study of the literature. Ann Intern Med 1986, 104:60-66.
26. Dellavance A., Alvarenga R.R., Rodrigues S.H., et al. Autoantibodies to 60kDa SS-A/Ro yield a specific nuclear myriad discrete fine speckled immunofluorescence pattern. J Immunol Methods 2013, 90:35-40.
27. Biagini R.E., Parks C.G., Smith J.P., et al. Analytical performance of the AtheNA MultiLyte ANA II assay in sera from lupus patients with multiple positive ANAs. Anal Bioanal Chem 2007, 388:613-618.
28. Peene I., Meheus L., Veys E.M., et al. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001, 60:131-136.
29. Shovman O., Gilburd B., Zandman-Goddard G., et al. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005, 38:105-109.
30. Avaniss-Aghajani E., Berzon S., Sarkissian A. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clin Vaccine Immunol 2007, 14:505-509.
31. Bizzaro N., Tozzoli R., Tonutti E., et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA auto antibodies: a collaborative study with the biomedical industry. J Immunol Methods 1998, 219:99-107.
32. Eissfeller P., Sticherling M., Scholz D., et al. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann N Y Acad Sci 2005, 1050:327-339.
33. Phan T.G., Bird D., Smithers K., et al. High-quality, cost-effective strategy for detection of autoantibodies to extractable nuclear antigens. Clin Diagn Lab Immunol 2001, 8:471-474.
34. Lock R.J., Unsworth D.J. Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?. J Clin Pathol 2001, 54:187-190.
35. Chan E.K., Fritzler M.J., Wiik A., et al. The IUIS/WHO/AF/CDC committee for the standardization of autoantibodies in rheumatic and related diseases - AutoAbSC.Org - Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007, 6:577-580.
36. Shoenfeld Y., Cervera R., Haass M., et al. EASI - The European Autoimmunity Standardisation Initiative: a new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann N Y Acad Sci 2007, 1109:138-144.
37. Meroni P.L., Biggioggero M., Pierangeli S.S., et al. Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol 2014, 10:35-43.
38. MacDonald K.L., Jackson J.B., Bowman R.J., et al. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med 1989, 110:617-621.
39. Verstegen G., Duyck M.C., Meeus P., et al. Detection and identification of antinuclear antibodies (ANA) in a large community hospital. Acta Clin Belg 2009, 64:317-323.